Taipei, Taiwan

Medeon Biodesign, Inc.

USPTO Granted Patents = 11

% Expired Patents = 36.4


Trademarks = 2

Forward Citations = 28

Loading Chart...
Loading Chart...

25 inventors (with patents filed for the assignee):

goldMedal Thomas Hsu (5 out of 9 patents)

silverMedal I-Ching Wu (4 out of 4 patents)

bronzeMedal Senzen Hsu (4 out of 4 patents)

4.  Carlos Castro (3 out of 11 patents)

5.  Hsiao-Wei Tang (3 out of 6 patents)

6.  Kathryn A Stecco (3 out of 3 patents)

7.  Damon Covell Campbell (2 out of 16 patents)

8.  John Stiggelbout (2 out of 2 patents)

9.  Torrey Smith (2 out of 2 patents)

10.  Hungwen Wei (2 out of 2 patents)

11.  Mengjhe Sie (2 out of 2 patents)

12.  Eric Y Hu (2 out of 2 patents)

13.  Po-Hua Lee (2 out of 2 patents)

14.  Shuling Cheng (2 out of 2 patents)

15.  Frank P Becking (2 out of 3 patents)


11 patents:

Company Overview
Medeon Biodesign, Inc. is a biotechnology company based in Taipei, Taiwan, specializing in the development and manufacturing of innovative medical devices and biopharmaceuticals. The organization focuses on harnessing advanced technologies to create solutions that enhance patient care and improve health outcomes. With a commitment to research and development, Medeon Biodesign aims to address unmet medical needs through cutting-edge products that integrate biological and engineering principles.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

Medeon Biodesign, Inc. USPTO Patent Assignee Logo
11 Patents

#362 in Taipei

#1,330 in Taiwan

#51,801 in the World

Taipei, TW
Taipei, Taiwan
Forward Citations = 28

25 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Medeon Biodesign, Inc.. Retrieved from https://idiyas.com/company/medeon-biodesign

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…